Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

=================

CHAMPIONS TACKLING MS - AWARDS Dinner, Honoring Aaron Boster, MD and Jon e. Glaser, DDS - now open for registration. Visit www.events.msvn.org

Tuesday, September 13, 2016

Myelin Repair, Shape Changers, Misdiagnoses, and Virtual Reality


                                                                  
  

Click here to receive MS news via e-mail




 SEPTEMBER 12, 2016 - BY IAN FRANKS 

Remyelination could be a new role in MS therapy for a drug that has been used to treat breast cancer for some 40 years.
Tamoxifen (brand name, Nolvadex), a widely used treatment for breast cancer, can also be used to treat myelin loss in patients with multiple sclerosis, a new study suggests.
The finding, by a team of researchers at the University of Cambridge, U.K., was published in a study titled “Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system” in the journal Scientific Reports.
Researchers used both in vitro cultures and a mouse model with reduced levels of myelin to analyze how six existing drugs might affect the repair and recovery of cells able to produce myelin, called oligodendrocytes.
“We’re very excited about our findings,” said Mark R.N. Kotter, the study’s senior author, in a news release. “What we discovered was that Tamoxifen can enhance myelin repair in MS by encouraging the brain’s own stem cells to regenerate myelin.”
Encouraging news indeed in the fight against MS. We need to halt progression and to repair the damaged myelin.

MS Views and News
Providing educational information, resources and services for those affected by MS

No comments: